Alberto Bona’s Exploit on the Class40 IBSA: Eighth at the Route Du Rhum
Thursday, November, 24, at 3:34:50 pm local time (8:34:50 Paris-Rome time) in Pointe-à-Pitre, Alberto Bona on the Class40 IBSA crossed the finish line of the twelfth edition of the Route du Rhum in eighth place. His race time is 15 days, 6 hours, 19 minutes and 50 seconds. The skipper of the Class40 IBSA sailed the 3,542 miles between Saint-Malo and Pointe-à-Pitre at a speed of 9.67 knots on the great-circle course, actually covering 4005.51 miles at an average speed of 10.93 knots. He arrived in Pointe-à-Pitre 1 day, 3 hours, 11 minutes and 10 seconds after the Class40 winner, Yoann Richomme.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20221125005116/en/
Alberto Bona on the Class40 IBSA crosses the finish line of the twelfth edition of the Route du Rhum (©IBSA | Beppe Raso)
“A very nice but extremely hard regatta, especially in the upwind week”, stated Alberto upon arrival. “I am extremely happy: IBSA and I made it together, we crossed an Atlantic that didn’t cut us any slack. A hard, unforgettable experience”.
The Ocean did not make concessions to anyone, but Bona was able to navigate with determination: “In the second disturbance, at night, I lost my wind station, I moved quickly to reach the helm and I hit my head. A tricky moment, no doubt, just like a few days ago when the spinnaker exploded. I replaced it with a bigger one, but the mast then started going down in the water, I had to cool it. Hence the eighth place, which is fine, just as I also know that there is still potential to be expressed”.
Started from Saint-Malo on November 9, the transoceanic regatta – which takes place every four years – saw a total of 138 solo skippers at the start, of whom 55 in Class40. The conditions of this edition proved to be exceptionally complex: after the three-day postponement to avoid a disturbance considered dangerous, the regatta was particularly tough, with an upwind navigation that engaged the Class40s for over a week.
THE BIG UPWIND – After a close-hauled start, the “walkway” in front of the iconic Cap Frehel and a demanding day of sailing already in the Channel, the skippers found themselves at the exit of the English Channel with winds up to 40 knots and rough seas: the Bay of Biscay immediately dictated its own conditions, putting the boats to the test and causing many withdrawals. Alberto Bona, at his first transatlantic regatta in Class40, has always been part of the leading group who – by choosing a more westerly route, far from the European coast – had to face three consecutive disturbances, while always sailing upwind.
It was a very difficult phase of the regatta, as breakdowns and damage affected navigation: Alberto Bona immediately had to deal with the malfunctioning of the main autopilot, due to the failure of the wind station, and this had very harsh consequences, forcing the skipper to spend many hours at the helm, a condition that put to the test his endurance and concentration. During the first days of navigation, Bona also suffered an injury, a cut on his forehead which he treated following the doctor’s instructions by radio.
“Navigating in the upwind conditions we found ourselves in was very difficult”, said Alberto. “It is a situation in which every movement on board is dangerous, and you are forced to remain still as much as possible, so as not to risk banging everywhere. At the same time, it is necessary to be alert, reactive and ready, because the boat has to be monitored and checked continuously, in order to intervene immediately and avoid greater damages”.
The “big upwind” lasted about a week, followed by a few days of wider sailing points and lighter winds: days that Alberto Bona used for what he called “DIY”, that is, a careful analysis of the hull and all the equipment, as well as all the work necessary to restore and prevent any damage.
THE AZORES AND THE CALM – The transition to the Azores, with the Class40 IBSA between the fifth and seventh position, in constant contact with the leaders, proved to be complex as well. The leading group of Class40s, in fact, chose to pass between the islands, gaining speed and miles over the rest of the fleet, but also requiring further attention and control. Then, to the South, the light wind and an uncooperative trade wind, which was late in showing itself, brought the leading group into an area with little wind, which was useful for recovering strength and defining the strategy for the second part of the regatta, characterised by broad reach sailing. In this stage, Alberto attempted a recovery at night, which allowed him to catch up with the leading group when he was about twenty miles behind, but the different weather conditions further along the course favoured the leaders again.
FICKLE TRADE WINDS – However, those who expected welcoming and gentle trade winds were immediately disappointed: the first group of Class40s had to wait longer than expected to catch the carrier winds, discovering that, once they arrived, they would never be steady.
The leaders benefitted from more wind and a better course, thus gaining an additional advantage. The Class40 IBSA showed excellent speed peaks, taking advantage of the moments of stronger wind. In fact, even a few miles away, conditions changed radically and the boats of the leading group sailed with different speeds and directions. Here, Bona tried the “Southern option”, to equalise his chances with the leaders, but the explosion of the heavy gennaker affected the last days of navigation: cross waves and fickle winds literally blew up the sail, and Alberto was left with the option of sailing with a masthead gennaker, to be manoeuvred continuously, but the bigger sail forced the mast into the water several times. To avoid any damage, Bona had to choose a more conservative trim, and the class40 IBSA settled in eighth position.
GUADELOUPE – The Route du Rhum is made up of many regattas within a regatta, and when Guadeloupe is sighted, after 3,500 miles of navigation, the last test begins: the circumnavigation of the island before crossing the finish line in Pointe-à-Pitre. This is the legendary endgame, between lighter winds and the management of navigation along the coast: for Bona it was a long day of navigation, before crossing the finish line in the afternoon and throw himself into the arms of his Cecilia, applauded and surrounded by the affection of the IBSA team, who had arrived in Guadeloupe to give him a warm welcome. Ambrogio Beccaria was also waiting for him on the quay.
“It was an exciting regatta, full of emotions, which kept us in suspense until the end. The Route du Rhum was a challenge for us from all points of view, and we are very proud of Alberto, of the result he achieved and of his excellent performance”, stated Arturo Licenziati, President and CEO of IBSA. “Alberto and the Class40 IBSA showed what is possible thanks to passion, determination and commitment, together with technology and innovation. We can say that both the skipper and his boat have been the perfect interpreters of IBSA’s vision”.
***
THE PROJECT: Sailing into the Future. Together started in January 2022; the partnership between IBSA and Alberto Bona was born on common bases and values, and aims to use sailing as a vehicle for corporate communication, towards the market and the nautical world. Ingenuity, courage, innovation, responsibility are elements that unite IBSA and Alberto, and the challenge of the Route du Rhum, in addition to the sporting race, also metaphorically represents the company’s history, philosophy and vision, which are always oriented towards the future and are part of a path that brings IBSA increasingly closer to the topics of environmental and social sustainability, inclusion and integration. The transatlantic regatta is the first stage of the three-year programme “Sailing Into The Future. Together” that the Swiss pharmaceutical company started with Bona.
THE BOAT: the boat with which Alberto Bona will participate in the Route du Rhum in November is a latest generation Class40, with a scow bow. Designed by French naval architect Sam Manuard and built by the JPS Production shipyard, the boat is a Mach 5 model, the latest evolution of Manuard’s Class40.
The characteristics: rounded bow, created with the aim of increasing performance while running; water lines and appendages designed to make the hull an all-round fast even upwind; large and protected cockpit to face navigation in the most comfortable and safe positions possible.
THE SKIPPER: Alberto Bona is from Turin, and has a degree in philosophy. As a university student, he won the Panerai trophy with Stormvogel, fast ULDB and historic boat with which he crossed the Atlantic Ocean for the first time, winning the ARC with a New Zealand crew. In 2012 he took part in the Minitransat, finishing 5th, one of the best Italian results ever in this category. In 2015 he switched to the prototype category Mini 6.50 with Promostudi La Spezia: he won the Italian championship and finished second in the ocean crossing Les Sables-Azores. In 2017 he discovered the Class40: on Giovanni Soldini’s formerTelecom Italia, he participated in the Transat Jacques Vabres, where he is forced to withdraw when he is in sixth place. In 2019 he was aboard the Maserati Multi 70 trimaran, one of the fastest boats in the world, where he practiced on the foils before moving on to the Figaro Beneteau 3, aboard which he participated in the Solitaire; the only Italian registered, he finished 7th among the rookies in the first year and 16th overall in 2020. In 2021 he won the Italian offshore team title and the Europeans in mixed doubles aboard the Figaro 3. In 2022 he starts the new project, with the support of the IBSA Group.
IBSA: IBSA (Institut Biochimique SA) is a Swiss multinational pharmaceutical Company, founded in 1945 in Lugano. Today, its products are present in over 90 Countries on 5 continents, through the Company’s 17 subsidiaries located in Europe, China, and the United States. The company has a consolidated turnover of 800 million CHF, and employs over 2,000 people between headquarters, subsidiaries and production sites. IBSA holds 90 families of approved patents, plus others under development, as well as a vast portfolio of products, covering 10 therapeutic areas: reproductive medicine, endocrinology, pain and inflammation, osteoarticular, aesthetic medicine, dermatology, uro-gynaecology, cardiometabolic, respiratory, consumer health. It is also one of the largest operators worldwide in the area of reproductive medicine, and one of the world’s leaders in hyaluronic acid-based products. IBSA has based its philosophy on four pillars: Person, Innovation, Quality and Responsibility.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20221125005116/en/
Contact information
FOR INFORMATION TO THE PRESS
IBSA Press Office – Italy
Valeria Riccobono – valeria.riccobono@noesis.net – mob: +39 392 9625892
Ornella Reccia – ornella.reccia@noesis.net – mob. +39 329 393 1922
IBSA Press Office – Switzerland
Francesca Rossini – notizie@laboratoriodelleparole.net – mob: +41 77 417 93 72
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
CORRECTING and REPLACING PHOTO Decode the Future of AI and Customer Experience at Elevate'25 Digital Innovation Summit18.9.2025 21:23:00 EEST | Press release
Please replace the photo with the accompanying corrected photo. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250918928987/en/ Gain insight and advice from firms at the frontier of AI-powered, mobile-first customer experiences. The release reads: DECODE THE FUTURE OF AI AND CUSTOMER EXPERIENCE AT ELEVATE'25 DIGITAL INNOVATION SUMMIT With keynotes from Google Cloud and an independent research firm, Elevate’25 will provide actionable strategies to harness the power of AI and create exceptional experiences for today's mobile-first consumer As unprecedented advancements in AI reshape consumer behavior, digital innovation summit Elevate'25 opened for general registration today. Sponsored by Airship, the exclusive, one-day event is designed to equip business leaders with proven strategies to harness artificial intelligence and mobile-first technology for a decisive competitive advantage. Taking place on October 15, 2025, at the i
Sai Life Sciences Opens Dedicated Facility for Veterinary APIs in Bidar, India18.9.2025 19:22:00 EEST | Press release
Sai Life Sciences (BSE: 544306 | NSE: SAILIFE), an innovator-focused Contract Research, Development, and Manufacturing Organization (CRDMO), today announced the opening of Unit VI, a dedicated facility for Veterinary Active Pharmaceutical Ingredient (API) production, in Bidar, India. Located alongside Unit IV, the company’s flagship API manufacturing site, Unit VI has been established exclusively for veterinary APIs. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250918612071/en/ Sai Life Sciences’ Veterinary APIs Unit in Bidar, India. The new facility is designed to meet the highest standards of safety, sustainability, and regulatory compliance, ensuring the production of high-quality APIs for veterinary applications. With this expansion, Sai Life Sciences aims to provide efficient and scalable manufacturing solutions to leading global animal health companies. Making the announcement, Krishna Kanumuri, CEO & Managing Direct
Celltrion Announces Commercial Availability of Omlyclo™ Across Europe at EADV 202518.9.2025 18:45:00 EEST | Press release
Celltrion, Inc. today showcased its longstanding commitment to expanding its biosimilar portfolio in the field of immuno-dermatology by attending the 2025 European Academy of Dermatology and Venereology (EADV) Congress, held 17-20 September in Paris, France. Following the European Commission (EC) approval of Omlyclo™, the first and only omalizumab biosimilar in Europe in May 2024, Omlyclo™ will be commercially available starting in Norway, with subsequent rollouts in European countries. As part of Celltrion’s mission to advance knowledge and understanding in dermatology, especially in chronic spontaneous urticaria (CSU), the company hosted satellite symposium presenting the results of the global Phase III clinical trial of Omlyclo™. The global Phase III clinical trial involved 619 patients with CSU, following them up to week 40. Patients were randomized to receive 300 mg or 150 mg of Omlyclo™, or reference product, every 4 weeks. Starting from week 12, patients who received Omlyclo™ we
Setting the Standard: AMRA Medical Recognized as one of TIME Magazine’s ‘World’s Top HealthTech Companies’18.9.2025 17:40:00 EEST | Press release
AMRA Medical is proud to share its inclusion in the World’s Top HealthTech Companies list, published today by TIME in collaboration with Statista. This recognition positions AMRA among an elite group of global innovators that are leading healthcare transformation. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250918372780/en/ AMRA Medical Recognized as one of TIME Magazine’s ‘World’s Top HealthTech Companies’ The selection, which comes just one week after celebrating AMRA’s 15 years of progress and innovation within the body composition space, highlights AMRA’s long-standing commitment to becoming a global leader in health informatics. By delivering detailed, reproducible insights within fat distribution and muscle composition, AMRA’s MRI-based technology is helping clinicians, researchers, and healthcare organizations unlock new levels of understanding across the metabolic and musculoskeletal sectors. “Being recognized by
illumynt, a CNE Direct Company, Is Pleased to Announce the Promotion of Jörg Herbarth to Chief Executive Officer (CEO)18.9.2025 17:30:00 EEST | Press release
illumynt, a CNE Direct company, is pleased to announce the promotion of Jörg Herbarth to Chief Executive Officer (CEO). Jörg has been a key member of illumynt’s executive leadership team since joining in June 2022, most recently serving as Chief Operating Officer. In his new role as CEO, Jörg will spearhead illumynt’s mission to become the number one provider of AI- and data-centric IT Asset Disposition (ITAD) solutions worldwide. Paul Knight, illumynt’s current CEO, will transition to the role of Founder & Chairman. In this capacity, Paul will continue to support the executive team with strategic guidance, while Jörg assumes full leadership of day-to-day operations and global expansion initiatives. Mr. Knight had come out of retirement a year ago to undertake some new initiatives and advance the company's strategic direction. With some necessary changes having taken place- he is thrilled to facilitate this transition to a reduced role again. Under Jörg’s leadership, illumynt will cont
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom